OccuLogix files $30 million shelf registration

By Devika Patel

Knoxville, Tenn., Feb. 12 - OccuLogix, Inc. filed a $30 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, depositary shares and warrants.

The securities may be structured as convertibles.

Proceeds will be used for research and development, to finance capital expenditures and capacity expansions and for general corporate purposes and working capital.

Boston-based OccuLogix develops ophthalmic devices to treat age-related eye diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.